NO20014624D0 - Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåte for fremstilling av vaksine mot Lyme-sykdom(borreliose) - Google Patents

Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåte for fremstilling av vaksine mot Lyme-sykdom(borreliose)

Info

Publication number
NO20014624D0
NO20014624D0 NO20014624A NO20014624A NO20014624D0 NO 20014624 D0 NO20014624 D0 NO 20014624D0 NO 20014624 A NO20014624 A NO 20014624A NO 20014624 A NO20014624 A NO 20014624A NO 20014624 D0 NO20014624 D0 NO 20014624D0
Authority
NO
Norway
Prior art keywords
lyme disease
borreliosis
preparation
monoclonal antibodies
preparing vaccine
Prior art date
Application number
NO20014624A
Other languages
English (en)
Other versions
NO20014624L (no
NO315905B1 (no
Inventor
Markus M Simon
Ulrich E Schaible
Klaus Eichmann
Michael Kramer
Wallich Reinhard
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25885304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20014624(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20014624L publication Critical patent/NO20014624L/no
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of NO20014624D0 publication Critical patent/NO20014624D0/no
Publication of NO315905B1 publication Critical patent/NO315905B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20014624A 1989-09-19 2001-09-24 Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåtefor fremstilling av passiv vaksine mot B. burgdorferi NO315905B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3931236 1989-09-19
DE4015911A DE4015911A1 (de) 1989-09-19 1990-05-17 Impfstoff gegen die lyme-krankheit

Publications (3)

Publication Number Publication Date
NO20014624L NO20014624L (no) 1991-03-20
NO20014624D0 true NO20014624D0 (no) 2001-09-24
NO315905B1 NO315905B1 (no) 2003-11-10

Family

ID=25885304

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19904062A NO311767B1 (no) 1989-09-19 1990-09-18 Patogen Borrelia burgdorferi-stamme, fremgangsmåte for fremstilling av et terapeutisk aktivt, isolert B. burgdorferi-OspA-antigen, rekombinant DNA, rekombinant vektor og fremgangsmåte forfremstilling av vaksine mot Lyme-sykdom (borreliose)
NO20014624A NO315905B1 (no) 1989-09-19 2001-09-24 Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåtefor fremstilling av passiv vaksine mot B. burgdorferi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19904062A NO311767B1 (no) 1989-09-19 1990-09-18 Patogen Borrelia burgdorferi-stamme, fremgangsmåte for fremstilling av et terapeutisk aktivt, isolert B. burgdorferi-OspA-antigen, rekombinant DNA, rekombinant vektor og fremgangsmåte forfremstilling av vaksine mot Lyme-sykdom (borreliose)

Country Status (24)

Country Link
US (6) US5178859A (no)
EP (5) EP0633313B1 (no)
JP (3) JP3205932B2 (no)
KR (2) KR100205462B1 (no)
AT (4) ATE131732T1 (no)
AU (1) AU651560B2 (no)
CA (1) CA2025597C (no)
CZ (2) CZ284538B6 (no)
DE (5) DE4015911A1 (no)
DK (4) DK0633028T3 (no)
ES (4) ES2082812T3 (no)
FI (1) FI102248B (no)
GR (3) GR3018995T3 (no)
HK (2) HK1002405A1 (no)
HR (1) HRP940545B1 (no)
HU (2) HU212716B (no)
IE (1) IE903377A1 (no)
NO (2) NO311767B1 (no)
NZ (1) NZ235260A (no)
PL (2) PL169804B1 (no)
PT (1) PT95349B (no)
SI (1) SI9011773B (no)
SK (3) SK456090A3 (no)
YU (2) YU48250B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
WO1993008306A1 (en) * 1991-10-22 1993-04-29 Symbicom Aktiebolag Improvement in borrelia burgdorferi diagnosis and prophylaxis
US5777095A (en) * 1988-10-24 1998-07-07 Symbicom Aktiebolag Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
US6143872A (en) * 1988-10-24 2000-11-07 Symbicom Aktiebolag Borrelia burdorferi Osp A and B proteins and immunogenic peptides
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
CA2084413A1 (en) 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
DK0465204T3 (da) * 1990-07-06 2000-10-09 American Home Prod Vaccine mod Lyme sygdom
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US6872550B1 (en) 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
EP0874051A3 (en) * 1991-08-15 1998-11-04 SMITHKLINE BEECHAM BIOLOGICALS s.a. OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
US6676942B1 (en) * 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
JPH06511154A (ja) * 1991-10-18 1994-12-15 コノート　ラボラトリーズ　インコーポレイテッド 組換えＢｏｒｒｅｌｉａタンパクの製造法
US6303129B1 (en) * 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
US6716591B1 (en) 1993-07-30 2004-04-06 Yale University B. burgdorferi polypeptides
US5656451A (en) * 1993-07-30 1997-08-12 Yale University OspE, OspF, and S1 polypeptides in borrelia burgdorferi
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US5558993A (en) * 1994-06-17 1996-09-24 The Regents Of The University Of California Cloned Borrelia burgdorferi virulence protein
GB9511909D0 (en) * 1995-06-12 1995-08-09 Microbiological Res Authority Vaccine
EP0894143B2 (en) 1996-02-21 2012-04-18 Board Of Regents, The University Of Texas System Vmp-like sequences of pathogenic borrelia
DE19632862B4 (de) 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
US6458555B1 (en) * 1996-08-21 2002-10-01 Gerd Bach Cytologic method of examining mucous membranes
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
DE19740735A1 (de) * 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
US6306623B1 (en) 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
ATE386805T1 (de) 1998-07-31 2008-03-15 Gundersen Lutheran Medical Fou Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
WO2000056298A2 (en) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Treatment of lyme disease with polysulfated glycosaminoglycan formulations
WO2000078345A1 (en) * 1999-06-21 2000-12-28 Milkhaus Laboratory, Inc. Method for treatment of lyme disease
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
US7847084B2 (en) 2002-12-20 2010-12-07 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic Borrelia species and strains
NZ576564A (en) 2006-11-03 2012-03-30 Schering Plough Ltd Canine lyme disease vaccine
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167537A2 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Compiled methods for analysing and sorting samples
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
AU2010322085B2 (en) * 2009-11-17 2016-09-15 Zoetis Services Llc Peptides and methods for the detection of Lyme disease antibodies
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
PL223175B1 (pl) 2012-10-22 2016-10-31 Inst Chemii Bioorganicznej Polskiej Akademii Nauk Szczepionka przeciw boreliozie, konstrukt genetyczny, rekombinowane białko, sposób otrzymywania konstruktu genetycznego, sposób otrzymywania szczepionki, sposób otrzymywania rekombinowanych białek, zastosowanie rekombinowanych białek do wytwarzania szczepionki przeciwko boreliozie
US9610336B1 (en) * 2014-07-16 2017-04-04 Amiram Katz Immunotherapy for lyme disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4772464A (en) 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4888276A (en) * 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5034515A (en) * 1987-09-22 1991-07-23 Wisconsin Alumni Research Foundation Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
ES2092560T5 (es) * 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease
DK0465204T3 (da) * 1990-07-06 2000-10-09 American Home Prod Vaccine mod Lyme sygdom
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
EP0874051A3 (en) * 1991-08-15 1998-11-04 SMITHKLINE BEECHAM BIOLOGICALS s.a. OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
ATE174378T1 (de) * 1991-08-27 1998-12-15 Novo Nordisk As Waschmittelzusammensetzungen
JPH06511154A (ja) * 1991-10-18 1994-12-15 コノート　ラボラトリーズ　インコーポレイテッド 組換えＢｏｒｒｅｌｉａタンパクの製造法
JPH07502646A (ja) * 1991-10-21 1995-03-23 メディミューン，インコーポレーテッド リポタンパク質の分泌シグナルをコード化するｄｎａを含む細菌発現ベクター

Also Published As

Publication number Publication date
JP3205932B2 (ja) 2001-09-04
DE4015911A1 (de) 1991-03-28
NO311767B1 (no) 2002-01-21
NO904062L (no) 1991-03-20
IE990173A1 (en) 2000-11-01
GR3032010T3 (en) 2000-03-31
JP3328644B2 (ja) 2002-09-30
PL170229B1 (pl) 1996-11-29
DK0418827T3 (da) 1996-05-06
ATE175576T1 (de) 1999-01-15
JP3418171B2 (ja) 2003-06-16
EP0633028B1 (de) 1999-11-17
KR910005889A (ko) 1991-04-27
NO20014624L (no) 1991-03-20
JPH03209400A (ja) 1991-09-12
ATE131732T1 (de) 1996-01-15
KR100202128B1 (en) 1999-06-15
SK151098A3 (en) 1999-04-13
DK0633313T3 (da) 2000-07-24
HK1002405A1 (en) 1998-08-21
SK280285B6 (sk) 1999-11-08
US5434077A (en) 1995-07-18
DE59010888D1 (de) 1999-12-23
CA2025597A1 (en) 1991-03-20
EP0418827A1 (de) 1991-03-27
HU212716B (en) 1996-10-28
JP2001204467A (ja) 2001-07-31
HRP940545B1 (en) 2000-06-30
HU211228A9 (en) 1995-11-28
HU905816D0 (en) 1991-03-28
SK151198A3 (en) 1999-04-13
EP0643974A1 (de) 1995-03-22
ATE191499T1 (de) 2000-04-15
AU6244490A (en) 1991-03-28
CZ97095A3 (en) 1995-09-13
SK283088B6 (sk) 2003-02-04
US5686267A (en) 1997-11-11
CZ456090A3 (cs) 1998-08-12
SK456090A3 (en) 1999-11-08
US5780030A (en) 1998-07-14
GR3018995T3 (en) 1996-05-31
EP0643974B1 (de) 1999-01-13
US5178859A (en) 1993-01-12
DK0633028T3 (da) 2000-04-10
HRP940545A2 (en) 1997-04-30
ES2141182T3 (es) 2000-03-16
EP0633313B1 (de) 2000-04-05
SI9011773A (sl) 1998-04-30
CZ284538B6 (cs) 1998-12-16
FI904597A0 (fi) 1990-09-18
PT95349A (pt) 1991-05-22
PT95349B (pt) 1997-06-30
EP0633028A1 (de) 1995-01-11
FI102248B1 (fi) 1998-11-13
EP0861664A3 (de) 1999-02-24
NO315905B1 (no) 2003-11-10
ES2129551T3 (es) 1999-06-16
AU651560B2 (en) 1994-07-28
YU9097A (sh) 1999-06-15
US5856447A (en) 1999-01-05
ES2145077T3 (es) 2000-07-01
PL169804B1 (pl) 1996-09-30
US6613331B1 (en) 2003-09-02
NZ235260A (en) 1993-04-28
EP0418827B1 (de) 1995-12-20
HK1013620A1 (en) 1999-09-03
ATE186646T1 (de) 1999-12-15
YU49370B (sh) 2005-09-19
DE59010903D1 (de) 2000-05-11
DE59010863D1 (de) 1999-02-25
DE59009978D1 (de) 1996-02-01
SI9011773B (en) 2001-12-31
CA2025597C (en) 2004-02-03
ES2082812T3 (es) 1996-04-01
FI102248B (fi) 1998-11-13
SK283089B6 (sk) 2003-02-04
GR3033675T3 (en) 2000-10-31
EP0861664A2 (de) 1998-09-02
YU48250B (sh) 1997-09-30
YU177390A (sh) 1993-05-28
DK0643974T3 (da) 1999-09-06
CZ284616B6 (cs) 1999-01-13
KR100205462B1 (ko) 1999-07-01
HUT59613A (en) 1992-06-29
IE903377A1 (en) 1991-04-10
NO904062D0 (no) 1990-09-18
EP0633313A1 (de) 1995-01-11
JP2001069969A (ja) 2001-03-21

Similar Documents

Publication Publication Date Title
NO20014624L (no) Fremgangsmåte for fremstilling av monoklonale antistoffer og fremgangsmåte for fremstilling av vaksine mot Lyme-sykdom(borreliose)
NO20020491D0 (no) CTL4A-reseptor, fusjonsproteiner som inneholder den og anvendelser derav
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
RU93058563A (ru) Полипептиды, иммунореагент, способ определения антител, способ индукции иммунного ответа, композиции, способ получения полипептида
DK0469045T3 (da) Syntetiske Pseudomonas aeruginosa pilinpeptider og beslægtede vacciner diagnostica
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
NO954318D0 (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
CA2347278A1 (en) Vaccine based on attenuated haemophilus somnus
RU95104722A (ru) Способ получения антител к коринебактериям дифтерии
MURAI CONGLUTININ-LIKE FACTORS IN HUMAN SALIVA RELATION TO OTHER SALIVARY AGGREGATING FACTORS